CEL SCI CORP
AI Executive Summary
AI-powered analysis of 10-Q filing content
CEL-SCI Corporation shows concerning deterioration with cash declining 43% to $6.3M in just one quarter, creating potential liquidity crisis. The biotech continues burning cash with $5.4M quarterly loss despite reduced R&D spending, while stockholders' equity dropped 30% to $11.1M, indicating accelerating financial distress.
Red Flags Detected (6)
Cash declined $4.7M (43%) in single quarter from $10.9M to $6.3M
Quarterly burn rate of ~$5.4M suggests cash runway of only 3-4 quarters
Stockholders' equity dropped 30% from $16.0M to $11.1M in one quarter
3 more red flags detected
Key Takeaways
Company is in critical cash management phase with limited runway
R&D expenses decreased 17% but still consuming $3.7M quarterly
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.